Article info
PDFCommentary
Body fatness and bevacizumab-based therapy in metastatic colorectal cancer
- Correspondence to Dr Andrew Renehan, Department of Surgery, University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK; arenehan{at}picr.man.ac.uk
Citation
Body fatness and bevacizumab-based therapy in metastatic colorectal cancer
Publication history
- First published March 5, 2010.
Online issue publication
April 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.